Merck

Merck has developed a cure for COVID 19 Molnupiravir Molnupiravir

Pharmaceutical company Merck reported, that has developed an effective cure for COVID-19 (Molnupiravir Molnupiravir). Shares of Merck and most airlines soared, while vaccine developer Moderna's papers fell by 11,4%. Merck and Ridgeback's research oral antiviral drug Molnupiravir reduced the risk of hospitalization or death by about 50 percent compared to placebo for patients with mild to moderate COVID-19 in a positive interim analysis of a phase study 3

Illumina Overview: microchips, DNA and coronavirus

Illumina Company (NASDAQ: ILMN) - American company, engaged in genetic research. Coronacrisis has spoiled her sales., but recovery is just around the corner. Investors should take into account the fact, that the company's expansion into more promising areas met with strong resistance from regulators.

Scroll to Top